Genetics & Genomics

Cancer Risks for Men With BRCA1/2 Mutations

genetic cancer syndromes, breast cancer, cancer screening, risk factors, prostate cancer
ONF 2013, 41(1), 99-101. DOI: 10.1188/14.ONF.99-101

Testing for mutations in breast cancer genes 1 and 2 (BRCA1/2) has been available since 1998, but much of the focus of this testing has been on the implications for women (Weitzel, Blazer, MacDonald, Culver, & Offit, 2011). Women who test positive face a lifetime risk of developing breast cancer of about 87% and about 45% for ovarian cancer, and are confronted with decisions about intensive screening or preventing the malignancies with the use of prophylactic surgery (e.g., bilateral mastectomy, bilateral salpingo-oophorectomy). Women and men who are BRCA 1/2 positive also may have an increased risk of pancreatic cancer and melanoma. However, the clinical implications for men who carry these mutations are not as clear (Pal et al., 2013).

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.